Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcomaMary Cianfrocca, Joseph A. Sparano, David M. Aboulafia et al.|Cancer|2010Cited by 171
Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcomaSteven A. Miles, Alvin E. Friedman‐Kien, Bruce J. Dezube et al.|AIDS|2002Cited by 55
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trialMary Cianfrocca, Joseph A. Sparano, Jamie Von Roenn et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 22
KAPOSI'S SARCOMA RESPONSE CRITERIAEllen G. Feigal, R. Wittes, Martin G. McCabe et al.|Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology|1997Cited by 3